Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
alexion pharmaceuticals
alnylam pharmaceutials
arrowhead pharmaceuticals
biotech
boehringer ingelheim
1
×
boston
1
×
boston blog main
boston top stories
clinical trials
1
×
deals
dicerna pharmaceuticals
eli lilly
hepatitis b
indiana blog main
indiana top stories
johnson & johnson
life sciences
national blog main
national top stories
neurodegenerative diseases
primary hyperoxaluria
rna interference
san francisco blog main
1
×
san francisco top stories
wisconsin blog main
wisconsin top stories
What
abandoning
ago
baggage
companies
cuts
deal
development
dicerna
free
gets
interference
long
medicines
pharma
1
×
rna
rnai
signs
1
×
small
wasn’t
Language
Current search:
pharma
×
boston
×
" boehringer ingelheim "
×
signs
×
" clinical trials "
×
" san francisco blog main "
×
@xconomy.com
5 years ago
Free of Baggage, Dicerna Cuts Another RNAi Deal and Gets $200M